Skip Navigation


Human Molecular Genetics Advance Access originally published online on August 5, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
12/19/2503    most recent
ddg266v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (49)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hussain, S.
Right arrow Articles by Mathew, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hussain, S.
Right arrow Articles by Mathew, C. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2003, Vol. 12, No. 19 2503-2510
DOI: 10.1093/hmg/ddg266
© 2003 Oxford University Press

Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1

Shobbir Hussain1, Emily Witt2, Pia A.J. Huber1, Annette L. Medhurst1, Alan Ashworth2 and Christopher G. Mathew1,*

1Division of Genetics and Development, Guy's, King's and St Thomas' School of Medicine, King's College London, 8th Floor, Guy's Tower, Guy's Hospital, London SE1 9RT, UK and 2Cancer Research UK Gene Function and Regulation Group, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK

Received May 9, 2003; Revised July 15, 2003; Accepted July 30, 2003

Fanconi anaemia (FA) is an autosomal recessive genetic disorder characterized by progressive bone marrow failure, multiple congenital abnormalities, and an increased risk of cancer. FA cells are characterized by chromosomal instability and hypersensitivity to DNA interstrand crosslinking agents. At least eight complementation groups exist (FA-A to G), and the genes for all of these except FA-B have been cloned. Functional linkage between the FA pathway and genes involved in susceptibility to breast cancer has been demonstrated by the interaction of the FANCA and FANCD2 proteins with BRCA1, and the discovery that the FANCD1 gene is identical to BRCA2. Here we have used the yeast two-hybrid system to test for direct interaction between BRCA2 or its effector RAD51 and the FANCA, FANCC and FANCG proteins. We found that FANCG was capable of binding to two separate sites in the BRCA2 protein, located either side of the BRC repeats. Furthermore, FANCG could be co-immunoprecipitated with BRCA2 from human cells, and FANCG co-localized in nuclear foci with both BRCA2 and RAD51 following DNA damage with mitomycin C. These results demonstrate that BRCA2 is directly connected to a pathway that is deficient in interstrand crosslink repair, and that at least one other FA protein is closely associated with the homologous recombination DNA repair machinery.

* To whom correspondence should be addressed. Tel: +44 2079554653; Fax: +44 2079554644; Email: christopher.mathew{at}kcl.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
A. Z. Al-Minawi, Y.-F. Lee, D. Hakansson, F. Johansson, C. Lundin, N. Saleh-Gohari, N. Schultz, D. Jenssen, H. E. Bryant, M. Meuth, et al.
The ERCC1/XPF endonuclease is required for completion of homologous recombination at DNA replication forks stalled by inter-strand cross-links
Nucleic Acids Res., October 1, 2009; 37(19): 6400 - 6413.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
R. K. Nookala, S. Hussain, and L. Pellegrini
Insights into Fanconi Anaemia from the structure of human FANCE
Nucleic Acids Res., March 12, 2007; 35(5): 1638 - 1648.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. L. Medhurst, E. H. Laghmani, J. Steltenpool, M. Ferrer, C. Fontaine, J. de Groot, M. A. Rooimans, R. J. Scheper, A. R. Meetei, W. Wang, et al.
Evidence for subcomplexes in the Fanconi anemia pathway
Blood, September 15, 2006; 108(6): 2072 - 2080.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
S. Tremblay, P. Pintor dos Reis, G. Bradley, N. N. Galloni, B. Perez-Ordonez, J. Freeman, D. Brown, R. Gilbert, P. Gullane, J. Irish, et al.
Young Patients With Oral Squamous Cell Carcinoma: Study of the Involvement of GSTP1 and Deregulation of the Fanconi Anemia Genes.
Arch Otolaryngol Head Neck Surg, September 1, 2006; 132(9): 958 - 966.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. Barroso, R.L. Milne, L.P. Fernandez, P. Zamora, J.I. Arias, J. Benitez, and G. Ribas
FANCD2 associated with sporadic breast cancer risk
Carcinogenesis, September 1, 2006; 27(9): 1930 - 1937.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. K. Thirumaran, J. L. Bermejo, P. Rudnai, E. Gurzau, K. Koppova, W. Goessler, M. Vahter, G. S. Leonardi, F. Clemens, T. Fletcher, et al.
Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin
Carcinogenesis, August 1, 2006; 27(8): 1676 - 1681.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Kitao, K. Yamamoto, N. Matsushita, M. Ohzeki, M. Ishiai, and M. Takata
Functional Interplay between BRCA2/FancD1 and FancC in DNA Repair
J. Biol. Chem., July 28, 2006; 281(30): 21312 - 21320.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
N. A Smirnova, P. J Romanienko, P. P Khil, and R D. Camerini-Otero
Gene expression profiles of Spo11-/- mouse testes with spermatocytes arrested in meiotic prophase I
Reproduction, July 1, 2006; 132(1): 67 - 77.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. E. Cohen, S. E. Pollack, and J. W. Pollard
Genetic Analysis of Chromosome Pairing, Recombination, and Cell Cycle Control during First Meiotic Prophase in Mammals
Endocr. Rev., June 1, 2006; 27(4): 398 - 426.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Taniguchi and A. D. D'Andrea
Molecular pathogenesis of Fanconi anemia: recent progress
Blood, June 1, 2006; 107(11): 4223 - 4233.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y.-G. Yang, Z. Herceg, K. Nakanishi, I. Demuth, C. Piccoli, J. Michelon, G. Hildebrand, M. Jasin, M. Digweed, and Z.-Q. Wang
The Fanconi anemia group A protein modulates homologous repair of DNA double-strand breaks in mammalian cells
Carcinogenesis, October 1, 2005; 26(10): 1731 - 1740.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. S. Lowenthal, A. I. Mehta, K. Frogale, R. W. Bandle, R. P. Araujo, B. L. Hood, T. D. Veenstra, T. P. Conrads, P. Goldsmith, D. Fishman, et al.
Analysis of Albumin-Associated Peptides and Proteins from Ovarian Cancer Patients
Clin. Chem., October 1, 2005; 51(10): 1933 - 1945.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X.-x. Tian, D. Rai, J. Li, C. Zou, Y. Bai, D. Wazer, V. Band, and Q. Gao
BRCA2 Suppresses Cell Proliferation via Stabilizing MAGE-D1
Cancer Res., June 1, 2005; 65(11): 4747 - 4753.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Ohashi, M. Z. Zdzienicka, J. Chen, and F. J. Couch
Fanconi Anemia Complementation Group D2 (FANCD2) Functions Independently of BRCA2- and RAD51-associated Homologous Recombination in Response to DNA Damage
J. Biol. Chem., April 15, 2005; 280(15): 14877 - 14883.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Mi and G. M. Kupfer
The Fanconi anemia core complex associates with chromatin during S phase
Blood, January 15, 2005; 105(2): 759 - 766.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Yamamoto, S. Hirano, M. Ishiai, K. Morishima, H. Kitao, K. Namikoshi, M. Kimura, N. Matsushita, H. Arakawa, J.-M. Buerstedde, et al.
Fanconi Anemia Protein FANCD2 Promotes Immunoglobulin Gene Conversion and DNA Repair through a Mechanism Related to Homologous Recombination
Mol. Cell. Biol., January 1, 2005; 25(1): 34 - 43.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Franco, H. J. van de Vrugt, P. Fernandez, M. Aracil, F. Arwert, and M. A. Blasco
Telomere dynamics in Fancg-deficient mouse and human cells
Blood, December 15, 2004; 104(13): 3927 - 3935.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. Taron, R. Rosell, E. Felip, P. Mendez, J. Souglakos, M. S. Ronco, C. Queralt, J. Majo, J. M. Sanchez, J. J. Sanchez, et al.
BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer
Hum. Mol. Genet., October 1, 2004; 13(20): 2443 - 2449.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-J. Park, S. L. M. Ciccone, B. D. Beck, B. Hwang, B. Freie, D. W. Clapp, and S.-H. Lee
Oxidative Stress/Damage Induces Multimerization and Interaction of Fanconi Anemia Proteins
J. Biol. Chem., July 16, 2004; 279(29): 30053 - 30059.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Wang, P. R. Andreassen, and A. D. D'Andrea
Functional Interaction of Monoubiquitinated FANCD2 and BRCA2/FANCD1 in Chromatin
Mol. Cell. Biol., July 1, 2004; 24(13): 5850 - 5862.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Hussain, J. B. Wilson, A. L. Medhurst, J. Hejna, E. Witt, S. Ananth, A. Davies, J.-Y. Masson, R. Moses, S. C. West, et al.
Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways
Hum. Mol. Genet., June 15, 2004; 13(12): 1241 - 1248.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
J. E. Lamerdin, N. A. Yamada, J. W. George, B. Souza, A. T. Christian, N. J. Jones, and L. H. Thompson
Characterization of the hamster FancG/Xrcc9 gene and mutations in CHO UV40 and NM3
Mutagenesis, May 1, 2004; 19(3): 237 - 244.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Hirsch, A. Shimamura, L. Moreau, S. Baldinger, M. Hag-alshiekh, B. Bostrom, S. Sencer, and A. D. D'Andrea
Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood
Blood, April 1, 2004; 103(7): 2554 - 2559.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.